Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-23-044806

Chief Accounting Officer sold 1,981.41 shares at $9.92 ($19,658)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weiss Amir Chief Accounting Officer 2023-08-04 Sale −1,981.41 $9.92 $19,658 42,442 D: show line 1 in the form
Open-market sales · 1,981.41 sh · avg $9.92 · $19,658
Loading xslF345X05/doc4.xml…